According to GlobalData, the worldwide thrombectomy device market was worth $2.96 billion in 2024 and is set to register a ...

Stryker has completed its $4.9 billion acquisition of Inari Medical, a company specializing in venous thromboembolism ...

Inari’s expertise combined with Stryker’s existing distribution and logistics network could boost volume and procedure ...

"Stryker concludes Inari Medical acquisition for $4.9bn" was originally created and published by Medical Device Network, a ...

The Portage, Michigan–based orthopedic and surgical device giant announced last month that it struck a deal to acquire Inari ...

Penumbra, Inc. (NYSE: PEN), the world's leading thrombectomy company, today reported financial results for the fourth ...

Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the acquisition of Inari Medical, Inc. (NASDAQ: NARI), a company that provides innovative solutions ...

Endovascular Engineering, Inc. (E2) announced it has secured $42 million in oversubscribed Series B financing to advance its n ...

Endovascular Engineering (E2) announced today that it raised $42 million in an oversubscribed Series B financing round.

Late-breaking data from the ENGULF trial showed that a novel dual-action thrombectomy device was effective and safe in treating acute pulmonary embolism (PE). The safety and effectiveness results ...

Mechanical thrombectomy is effective and safe for treating pulmonary embolism (PE). Although the Tendvia mechanical thrombectomy system has been validated in pigs, further evidence supporting its ...